References
1. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus. Deboer DJ, Schafer JH, Salsbury CS, et al. Am J Vet Res 63:408-413, 2002.
2. Investigation on the clinical efficacy and tolerability of a 0.4% topical stannous fluoride preparation (MedEquine Gel) for the treatment of bacterial skin infections in horses: A prospective, randomized, double-blinded, placebo-controlled clinical trial. Marsella R, Akucewich L. Vet Dermatol 18:444-450, 2007.
3. Investigation of the clinical efficacy of 0.2% topical stannous fluoride for the treatment of canine superficial pyoderma: A prospective, randomized, double-blinded, placebo-controlled trial. Seltzer JD, Flynn-Lurie AK, Marsella R, Brennan MM. Vet Dermatol 21:249-258, 2010.
4. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. Piekutowska A, Pin D, Rème CA, et al. Comp Pathol 138:197-203, 2008.
5. Anti-scratching behavioral effects of Nstearoyl-phytosphingosine and 4-hydroxysphinganine in mice. Ryu KR, Lee B, Lee IA, et al. Lipids 45:613-618, 2010.
6. Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: Disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. Bäumer W, Rossbach K, Mischke R, et al. J Invest Dermatol 131:266-288, 2011.